Zobrazeno 1 - 10 of 38 pro vyhledávání: '"Malin, JJ"'
1
Akademický článek
Therapeutic compounds targeting Lipid II for antibacterial purposes
Autor: Malin JJ, de Leeuw E
Publikováno v: Infection and Drug Resistance, Vol Volume 12, Pp 2613-2625 (2019)
Jakob J Malin,1,2 Erik de Leeuw31University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany; 2Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 3Institute of Human
Externí odkaz: https://doaj.org/article/8c409bd5d4684ab99150d7a615bb9287
Zobrazit plný text záznamu
3
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis
Autor: Beckerman, R, Gori, A, Jeyakumar, S, Malin, JJ, Paredes, R, Povoa, P, Smith, NJ, Teixeira-Pinto, A
Publikováno v: Scientific Reports
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
This network meta-analysis (NMA) assessed the efficacy of remdesivir in hospitalized patients with COVID-19 requiring supplemental oxygen. Randomized controlled trials of hospitalized patients with COVID-19, where patients were receiving supplemental
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::386d797e06a431cda109151b179fcec7
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7108
Zobrazit plný text záznamu
5
Akademický článek
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19.
Autor: Kalil AC; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA., Chandak A; Evidence and Access, Certara, New York, New York, USA., Moore LSP; Department of Infectious Diseases, Imperial College, London, United Kingdom., Ahuja N; Department of Internal Medicine, Stanford University School of Medicine, Stanford, California, USA., Kolditz M; Medical Department I, Division of Pulmonology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany., Casciano R; Evidence and Access, Certara, New York, New York, USA., Kadambi A; Evidence and Access, Certara, New York, New York, USA., Yaghoubi M; Evidence and Access, Certara, New York, New York, USA., Tsiodras S; Professor of Medicine and Infectious Diseases, National & Kapodistrian University of Athens Medical School, Chair, 4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece., Malin JJ; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Mozaffari E; Medical Affairs, Gilead Sciences, Foster City, California, USA., Bartoletti M; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Infectious Disease Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Dec 13; Vol. 79 (Supplement_4), pp. S160-S166.
Zobrazit plný text záznamu
6
Akademický článek
Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administration.
Autor: Kurup S; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA. sree.kurup@boehringer-ingelheim.com., de Mendizabal NV; Metrum Research Group, Tariffville, CT, 06081, USA.; Gilead, Foster City, CA, 94404, USA., Becker S; Institute of Virology, Philipps University Marburg, 35043, Marburg, Germany.; German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, 35043, Marburg, Germany., Bolella E; Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 06877, USA., De Sousa D; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA., Fätkenheuer G; Department of Internal Medicine 1, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931, Cologne, Germany., Gruell H; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany., Klein F; German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, 35043, Marburg, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931, Cologne, Germany.; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931, Cologne, Germany., Malin JJ; Department of Internal Medicine 1, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50937, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50931, Cologne, Germany., Schmid U; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach an der Riss, Germany., Korell J; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.; Metrum Research Group, Tariffville, CT, 06081, USA.
Publikováno v: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Dec 05; Vol. 52 (1), pp. 3. Date of Electronic Publication: 2024 Dec 05.
Zobrazit plný text záznamu
7
Akademický článek
Efficacy and safety of molnupiravir for the treatment of SARS-CoV-2 infection: a systematic review and meta-analysis.
Autor: Malin JJ; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Centre for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany., Weibel S; Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Germany., Gruell H; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Kreuzberger N; Evidence-Based Medicine, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Stegemann M; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität of Berlin, Berlin, Germany., Skoetz N; Evidence-Based Medicine, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2023 Jul 05; Vol. 78 (7), pp. 1586-1598.
Zobrazit plný text záznamu
8
Akademický článek
Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV.
Autor: Malin JJ; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany., Suárez I; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Biehl LM; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Site Bonn-Cologne, Cologne, Germany., Schommers P; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Site Bonn-Cologne, Cologne, Germany., Knops E; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Di Cristanziano V; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Heger E; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Pflieger E; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Wyen C; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Bettin D; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Rybniker J; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany., Fätkenheuer G; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Lehmann C; Department I of Internal Medicine, Division of Infectious Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Site Bonn-Cologne, Cologne, Germany.
Publikováno v: HIV medicine [HIV Med] 2023 Jul; Vol. 24 (7), pp. 785-793. Date of Electronic Publication: 2023 Mar 08.
Zobrazit plný text záznamu
9
Akademický článek
Longitudinal fluctuations of common antimicrobial resistance genes in the gut microbiomes of healthy Dutch individuals.
Autor: Malin JJ; Department of Medical Microbiology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands., von Wintersdorff CJH; Department of Medical Microbiology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands. Electronic address: c.von.wintersdorff@mumc.nl., Penders J; Department of Medical Microbiology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Medical Microbiology, Care and Public Health Research Institute CAPHRI, Maastricht University Medical Centre, Maastricht, the Netherlands., Savelkoul PHM; Department of Medical Microbiology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Medical Microbiology, Care and Public Health Research Institute CAPHRI, Maastricht University Medical Centre, Maastricht, the Netherlands., Wolffs PFG; Department of Medical Microbiology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Medical Microbiology, Care and Public Health Research Institute CAPHRI, Maastricht University Medical Centre, Maastricht, the Netherlands.
Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2023 Mar; Vol. 61 (3), pp. 106716. Date of Electronic Publication: 2023 Jan 11.
Zobrazit plný text záznamu
10
Akademický článek
[Recurrent SARS-CoV-2 infections in immunodeficiency].
Autor: Tometten L; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland., Malin JJ; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland., Pracht E; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland., Bröckelmann PJ; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland., Horn C; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland., Sprute R; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland., Langhorst CA; Medizinische Fakultät und Uniklinik Köln, Klinik für Dermatologie und Venerologie, Universität zu Köln, Köln, Deutschland., Hallek M; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland., Fätkenheuer G; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland., Rybniker J; Klinik I für Innere Medizin, Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland. Jan.rybniker@uk-koeln.de.
Publikováno v: Innere Medizin (Heidelberg, Germany) [Inn Med (Heidelb)] 2023 Jan; Vol. 64 (1), pp. 84-87. Date of Electronic Publication: 2022 Oct 28.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje